Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis

OBJECTIVE: To evaluate the impact on structural lesions observed on MRI in the sacroiliac joints (SIJ) at 12 weeks in patients with non-radiographic axial spondyloarthritis (nr-axSpA) receiving etanercept or placebo in EMBARK (Effect of Etanercept on Symptoms and Objective Inflammation in nr-axSpA,...

Descripción completa

Detalles Bibliográficos
Autores principales: Maksymowych, Walter P, Wichuk, Stephanie, Dougados, Maxime, Jones, Heather E, Pedersen, Ron, Szumski, Annette, Marshall, Lisa, Bukowski, Jack F, Lambert, Robert G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754741/
https://www.ncbi.nlm.nih.gov/pubmed/28970212
http://dx.doi.org/10.1136/annrheumdis-2017-211605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754741/
https://www.ncbi.nlm.nih.gov/pubmed/28970212
http://dx.doi.org/10.1136/annrheumdis-2017-211605

Ejemplares similares